Actively Recruiting
The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE Trial
Led by Liverpool Heart and Chest Hospital NHS Foundation Trust · Updated on 2025-11-24
100
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
Sponsors
L
Liverpool Heart and Chest Hospital NHS Foundation Trust
Lead Sponsor
R
Rampart Health, L.L.C.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Doctors and nurses who perform heart procedures using X-ray guidance are exposed to radiation, which can be harmful over time. This exposure increases the risk of certain health problems, including cancers, eye damage (cataracts), and DNA damage. Although protective lead clothing is used to reduce exposure, it is heavy, uncomfortable, and can cause muscle and joint problems for those who wear it daily. A new radiation protection device, called RAMPART, may help reduce radiation exposure for heart specialists and their teams. It could also allow them to wear lighter protective gear-or none at all-making their work safer and more comfortable. This study will compare the radiation levels received by doctors and nurses during heart procedures when using RAMPART versus standard protection. By doing so, we hope to find out if this new device can better protect medical teams from radiation, improving both their safety and well-being.
CONDITIONS
Official Title
The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Procedures involving adult patients (greater than 18 years of age)
- Male or female patients
- Planned to undergo elective or urgent coronary intervention procedure with ionising radiation in the cardiac catheter lab via right or left radial arteries
You will not qualify if you...
- Procedures involving patients younger than 18 years
- Patients unable to give valid consent
- Pregnancy
- Procedures using femoral artery approach
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Liverpool Heart & Chest Hospital
Liverpool, United Kingdom, L14 3PE
Actively Recruiting
Research Team
J
John D Hung, MBChB PhD MRCP(UK)
CONTACT
D
Debar Rasoul, MBChB BSc MRCP(UK)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here